Cargando…
Clinicopathological Characteristics of NRG1 Fusion–Positive Solid Tumors in Korean Patients
PURPOSE: Neuregulin 1 (NRG1) gene fusion is a potentially actionable oncogenic driver. The oncoprotein binds to ERBB3-ERBB2 heterodimers and activates downstream signaling, supporting a therapeutic approach for inhibiting ERBB3/ERBB2. However, the frequency and clinicopathological features of solid...
Autores principales: | Cha, Yoon Jin, Lee, Chung, Joo, Bio, Kim, Kyung A, Lee, Choong-kun, Shim, Hyo Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582527/ https://www.ncbi.nlm.nih.gov/pubmed/37321274 http://dx.doi.org/10.4143/crt.2023.682 |
Ejemplares similares
-
Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2020) -
NRG1 fusions in breast cancer
por: Howarth, Karen D., et al.
Publicado: (2021) -
PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors
por: Cha, Yoon Jin, et al.
Publicado: (2017) -
Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants
por: Cha, Yoon Jin, et al.
Publicado: (2016) -
Clinicopathologic Review of Ovarian Masses in Korean Premenarchal Girls
por: Ki, Eun Young, et al.
Publicado: (2013)